CD8A and cancer: In CRCs TME, IL-17 restricts immune surveillance, inhibits the infiltration of CD8+ T cells, recruits MDSCs by inducing G-CSF production, and promotes cancer-elicit inflammation, favoring the formation of cancer-supportive niches [143,144,145].